CTSI-RAP at UCLA

What CTSI-RAP at UCLA does

UCLA CTSI is a non-profit academic research institute within the University of California, Los Angeles, established in 2011 under the NIH National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) program. It operates as a four-institution consortium with Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science, and the Lundquist Institute at Harbor-UCLA Medical Center, supporting clinical and translational research across Los Angeles County. As of 2022, the institute is funded through a $59 million five-year CTSA renewal, the second such renewal since inception.

The institute's core offerings span five pillars: Clinical and Translational Research Centers (CTRCs) providing clinical trial facilities across partner institutions; education and training programs including the CTSI-RAP research associates program for high school and undergraduate students, the TL1 pre/postdoctoral training program, and the KL2 junior faculty career development program; Community Engagement and Research Program (CERP) facilitating community-partnered research; data and informatics tools including REDCap, cohort identification, and the Los Angeles Data Resource (a federation of clinical warehouses across five institutions covering 7M+ de-identified patient records); and the Grant Submission Unit providing boilerplate and letter-of-support services. Supporting units include the Embedded Clinical Research and Innovation Unit (ECRI) for study recruitment and the Dissemination, Implementation and Improvement (DII) initiative.

The institute is funded almost entirely through federal and state grants (NIH NCATS, NIH Institute grants, California state funding) and provides its services free of charge to UCLA CTSI-affiliated researchers. It does not generate commercial revenue. Scale metrics include 2,100+ investigators supported, 10,000+ annual clinical research visits, 1,080+ trainees trained in the first decade, and 30+ community partners. The 2022-2025 period shows continued grant momentum including $25M HIV research, $25.3M street medicine, $6M CERP community-led research, and California precision medicine funding ($8.3M combined).

Name

CTSI-RAP at UCLA

Legal name

Clinical & Translational Science Institute

Website

https://ctsi.ucla.edu

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

UCLA CTSI is a non-profit academic research institute funded by NIH NCATS that provides clinical and translational research infrastructure, training, and community engagement across a four-institution consortium in Los Angeles County.

Ownership category

akta.pro rank

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. NIH NCATS Clinical and Translational Science Award: Primary funding from National Center for Advancing Translational Sciences (NCATS) through a $59 million five-year Clinical and Translational Science Award grant supporting the UCLA CTSI partnership among UCLA, Charles Drew University, Lundquist Institute, and Cedars-Sinai
2. Training Grant Support (T32): NIH institutional training grants supporting pre-doctoral and postdoctoral programs in clinical and translational science
3. Pilot Funding and Grants: Various pilot grants including CERP awards, safety-net health innovation awards, and project-specific funding

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

CTSI-RAP at UCLA is a research training and support program within UCLA's Clinical & Translational Science Institute that provides clinical research infrastructure, training, community engagement, and data informatics services to academic investigators and partner institutions. The institute supports the full translational research pipeline through Clinical Research Centers, embedded clinical research innovation, grant submission support, and dedicated training pathways (TL1, KL2, RAP).

Product overview

CTSI-RAP at UCLA is part of the UCLA Clinical and Translational Science Institute (CTSI), a research partnership among UCLA, Charles Drew University of Medicine and Science, the Lundquist Institute at Harbor-UCLA Medical Center, and Cedars-Sinai Medical Center. The organization offers a comprehensive portfolio of research support services organized around five pillars: (1) Clinical and Translational Research Centers (CTRCs) providing inpatient/outpatient research facilities; (2) Education and Training programs including the CTSI-RAP research associates program for high school/undergraduate students, TL1 pre/postdoctoral training, and KL2 faculty career development; (3) Community Engagement through the Community Engagement and Research Program (CERP) facilitating academic-community partnerships; (4) Data and Informatics tools including REDCap, cohort identification, and genomic data access; and (5) Grant Support services through the Grant Submission Unit. Additional offerings include the Embedded Clinical Research and Innovation Unit (ECRI) for study recruitment and operations support, and the Dissemination, Implementation and Improvement (DII) initiative for translating research into practice.

Differentiator

Problem solved

Functional benefit

Brands

• CTSI-RAP: Research Associates Program - A training program within CTSI that provides research opportunities for high school and undergraduate students.
• Community Engagement and Research Program (CERP)
• UCLA CTSI ResearchGO
• TL1 Program
• KL2 Translational Science Scholars Program

Products and services

• CTSI-RAP (Research Associates Program) Structured clinical and translational research training program for UCLA students and trainees, providing hands-on research experience within the CTSI environment.
• Clinical Research Centers (CTRCs) Clinical Research Centers providing dedicated inpatient and outpatient research facilities, nursing, and core lab services to support clinical and translational research studies conducted by affiliated investigators.
• Embedded Clinical Research and Innovation Unit (ECRI) Embedded clinical research and innovation unit that places research staff within clinical settings to support investigator-initiated studies, with the goal of accelerating translational research at the point of care.
• DII Initiative Initiative within UCLA CTSI providing structured programming and presentations on clinical and translational research topics to CTSI investigators and partners.
• Community Engagement and Research Program (CERP) Community Engagement and Research Program that supports community-partnered research, health equity initiatives, and partnerships with community-based organizations across the greater Los Angeles region.
• Grant Submission Unit (GSU) Grant Submission Unit providing grant preparation, review, and submission services to support CTSI investigators in securing extramural research funding.
• Data and Informatics Tools Data and informatics tools including REDCap for clinical data capture and the Los Angeles Data Resource for population and clinical data access, made available to CTSI investigators and partners.
• TL1 Training Program Predoctoral training program in clinical and translational research, providing mentored research training to graduate students and postdoctoral trainees within the CTSI.
• KL2 Translational Science Scholars Program Career development program for early-career clinical and translational investigators, providing mentored training and protected research time as Translational Science Scholars.

Quantifiable outcome

• Supported participation of underrepresented groups in vaccine trials to greater than 65%
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• NIH National Center for Advancing Translational Sciences (NCATS)coreStrategic or Co-development Partner · 29 June 2022Primary federal funder through $59 million Clinical and Translational Science Award. NCATS coordinates the 60-member CTSA consortium that UCLA CTSI participates in to accelerate translation of scientific discoveries into health interventions.
• Cedars-Sinai Medical CentercoreStrategic or Co-development PartnerOne of four partner institutions in UCLA CTSI consortium. Contributes to clinical research, precision medicine, and translational science programs. Provides clinical research center facilities and expertise.
• Charles R. Drew University of Medicine and SciencecoreStrategic or Co-development PartnerPartner institution focused on health disparities research and minority health. Contributes to community engagement and health equity initiatives within the UCLA CTSI consortium.
• The Lundquist Institute at Harbor-UCLA Medical CentercoreStrategic or Co-development PartnerPartner institution contributing biomedical innovation research expertise. Provides Lundquist/Harbor-UCLA CTRC facilities and supports translational science initiatives.
• Los Angeles County Department of Health ServicescoreStrategic or Co-development PartnerMajor research partnership affecting care provided by 270+ physicians and outcomes for 80,000+ patients. Joint programs include DHS-UCLA-USC Implementation Science Program and quality improvement initiatives.
• University of Southern California (USC)minorStrategic or Co-development PartnerCollaborating institution in Los Angeles Data Resource federation and synergistic research initiatives including CLIC-supported synergy paper team.
• NIH Community Engagement Alliance (CEAL)coreStrategic or Co-development PartnerSupported UCLA CTSI's statewide collaborative effort across 11 academic institutions and 75+ community partners to increase vaccination rates and clinical trial participation for at-risk populations.
• California Institute for Regenerative Medicine (CIRM)minorStrategic or Co-development PartnerCIRM funds UCLA Health Alpha Clinic providing stem cell and gene therapy research support. One of nine CIRM-funded Alpha Clinics nationally.
• Center for Leading Innovation and Collaboration (CLIC)minorStrategic or Co-development PartnerCTSA coordinating center that selected UCLA as part of first CLIC-funded synergy paper team for academic-public partnership model.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Others

• Center for Leading Innovation and Collaboration (CLIC): The CTSA coordinating center that supports cross-hub collaboration, training, and synergy initiatives. Thematically related as the consortium infrastructure layer enabling UCLA CTSI's participation in multi-site translational research.

Direct peers

• Oregon Clinical and Translational Research Institute (OCTRI): OHSU's CTSA-funded institute offering clinical research support, pilot funding, training, and community engagement. Comparable scope and federal grant funding model to UCLA CTSI.
• Harvard Catalyst: Harvard University's CTSA-funded translational science institute supporting investigators across Harvard Medical School affiliates. Directly comparable to UCLA CTSI as one of the largest CTSA hubs with similar pillars (clinical research support, training, community engagement, data resources).
• Scripps Research Translational Institute: Scripps Research's translational science institute focused on genomics, digital health, and individualized medicine. Comparable as a CTSA-affiliated translational research hub with emphasis on emerging trial technologies.
• Johns Hopkins Institute for Clinical and Translational Research (ICTR): Johns Hopkins University's CTSA-funded translational research institute offering clinical research infrastructure, training programs (TL1, KL2), biostatistics, and community engagement. Highly comparable in mission, structure, and federal funding model.
• Duke Clinical and Translational Science Institute: Duke University's CTSA-funded institute delivering clinical research support, training, and community engagement programs. Operates under the same NCATS CTSA framework as UCLA CTSI with comparable service pillars.
• Georgia CTSA (Emory / Georgia Tech / Morehouse): Multi-institution CTSA hub in Georgia providing translational research support, training, and community engagement. Comparable multi-institution partnership model to UCLA CTSI's consortium with Cedars-Sinai, Charles Drew, and Lundquist.
• Vanderbilt Institute for Clinical and Translational Research (VICTR): Vanderbilt's CTSA hub providing biostatistics, bioinformatics, clinical research centers, and training programs. Direct peer under the federal CTSA program with overlapping translational science infrastructure.
• University of Pennsylvania ITMAT: UPenn's Institute for Translational Medicine and Therapeutics, a CTSA hub providing translational research infrastructure, training, and clinical research support. Comparable scope and federal funding model.

Broad incumbents

• NCATS (National Center for Advancing Translational Sciences): The NIH institute that funds and coordinates the CTSA consortium of which UCLA CTSI is a member. Broad incumbent defining program scope, funding levels, and evaluation metrics for all CTSA hubs.

Market position

Weaknesses2 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ctsi-rap-at-ucla

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CTSI-RAP at UCLA